CIRCASSIA PHARMACEUTICAL PLC ORDINARY SH (OTCMKTS:CSSPF) Sellers Reduced By 12.28% Their Shorts As Of Apr 16, 2018

April 16, 2018 - By Michele Cranor

CIRCASSIA PHARMACE (OTCMKTS:CSSPF) Corporate Logo

It was noted a decrease on CIRCASSIA PHARMACEUTICAL PLC ORDINARY SH (OTCMKTS:CSSPF)’s shorted shares with 12.28%. FINRA issued in April CSSPF’s total 182,200 shorted shares. That’s 12.28% down from 207,700 shares. CIRCASSIA PHARMACEUTICAL PLC ORDINARY SH float short is 0.08%.

The last price was $1.3.It’s since April 16, 2017 and is 0.00% down. The stock underperformed the S&P500 by 11.55%.

Circassia Pharmaceuticals plc, a specialty biopharmaceutical company, focuses on the development and commercialization of products for the treatment of asthma and chronic obstructive pulmonary disease .The firm is worth $. It markets novel NIOX asthma management products directly to specialists in the United States, the United Kingdom, and Germany, as well as through a network of partners internationally.Last it reported negative earnings. The companyÂ’s asthma products comprise Fliveo that targets substitution of Flixotide, which has approved in the United Kingdom, as well as developing Seriveo that targets direct substitution of Seretide.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: